Available online www.jocpr.

com

Journal of Chemical and Pharmaceutical Research, 2016, 8(5):505-526

ISSN : 0975-7384
Review Article CODEN(USA) : JCPRC5

The chemistry and biological significance of imidazole, benzimidazole,

benzoxazole, tetrazole and quinazolinone nucleus
*
Maruthamuthu, Shameela Rajam, Christina Ruby Stella P., Bharathi Dileepan A. G.
and R. Ranjith

PG & Research Department of Chemistry, Bishop Heber College, (Autonomous), Affiliated Bharathidasan
University, Tiruchirapalli -17 Tamilnadu, India
_____________________________________________________________________________________________

ABSTRACT

The imidazole, benzimidazole, benzoxazole, tetrazole and quinazolinone are heterocyclic aromatic organic
compounds. It is an important pharmacophore and privileged structure in medicinal chemistry. It plays a very
important role with plenty of useful therapeutic activities such as antiulcers, antihypertensives, analgesic, anti-
inflammatory, anti-virals, antifungals, anticancer, antidepressant activity, antilishmanial activity, anticonvulsant
activity, antitubercular activity, antitumor activity, cyclooxygenase-2 inhibiting activity, DNA Topoisomerase
inhibiting activity, antileukemic activity, antimalarial activity, antioxidant activity, antileishmanial activity and
antihistaminics. The review of the literature shows that the imidazole, benzimidazole, benzoxazole, tetrazole and
quinazolinones derivatives are outstandingly effective compounds and a large number of reviews available for
biochemical and pharmacological studies conformed that their molecules are useful against a wide variety of micro-
organisms. Because of their importance, the methods for their synthesis have become a focus of synthetic organic
chemists. Therefore in the present review we tried to compile the chemistry of different derivative of substituted
imidazole, benzimidazole, benzoxazole, tetrazole and quinazolinones as well as various pharmacological activities
and some of the important methodologies used for the synthesis.
_____________________________________________________________________________________________

INTRODUCTION

Research in the field of pharmaceutical chemistry has its most important task in the development of new and better
drugs and their successful introduction into clinical practice. The word 'drug' is derived from the French word
'drogue' which means a dry herb. In general way, a drug may be defined as a substance used in the prevention,
diagnosis, treatment or cure of disease in man or other animals. The basis of understanding in the medicinal
chemistry lies in awareness of the relation between the chemistry of a particular compound or group of compounds
and their interactions with the body, which is known as structure activity relation and the mechanism by which the
compound influences the biological system, is known as its mode of action.

Human health is impacted by a large variety of chemical substances, including those essential to human life, such as
vitamins and nutrients and medicines. Natural substances are intrinsically exhibit superior properties with regard to
efficacy and safety in matters related to human health. As it is difficult to meet the worldwide demand of the
requirement of the natural products due to their low abundance in nature, it is essential to produce synthetic
substances in large quantities. This can extend to so-called nature identical materials that are natural substances
produced synthetically in an identical or with slight modification of the molecular form, in order to increase the
biological activity of the molecule. Heterocycles are among the most frequently encountered scaffolds in drugs and
pharmaceutically relevant substances. The remarkable ability of heterocyclic nuclei to serve both as biomimetics and
reactive pharmacophores has largely contributed to their unique value as traditional key elements of numerous
drugs. The development of heterocycles as scaffolds, containing a high degree of diversity has become a leading
focus in modern drug discovery. In this research program the derivatives of various diverse classes of heterocycles

505
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
e.g., imidazole, benzimidazole, benzoxazole, tetrazole, and quinazolinone were developed. Certain possible
modifications on the heterocyclic ring by the addition of diverse substituents may lead to new products with better
biological profiles. As a result of the biological activity exhibited by the heterocyclic molecules, the development of
new chemical entities (NCEs) is the focus of intense activity in pharmaceutical industry. Various types of newly
synthesized molecules may be very good at blocking the action or killing the pathogens without harming the human
cells so as to prevent or cure the disease. The nitrogen, oxygen and sulphur heterocycles are an attractive source of
compounds for the identification of new biological probes. The main aim is to design and synthesize molecules
involving the use of structural motif commonly found in majority of well-established drug molecules. The research
work is mainly concentrated on the above points.

1.1 Heterocycles
Heterocycles are organic compounds containing at least one atom of carbon, and at least one element other than
carbon, such as sulfur, oxygen or nitrogen within a ring structure Eicher et al., (2003)1. Heterocyclic chemistry is the
branch of chemistry dealing with synthesis, properties, and applications of heterocycles. The history of heterocyclic
chemistry began in the 1800's, in step with the development of organic chemistry. Some noteworthy developments:
Campaigne et al.,(1986)2 1818: Brugnatelli isolates alloxan from uric acid; 1832: Dobereiner produces furfural (a
furan compound) by treating starch with sulfuric acid; 1834: Runge obtains the pyrrole ("fiery oil") by dry
distillation of bones; 1906: Friedlander synthesizes indigo, allowing synthetic chemistry to displace a large
agricultural industry; 1936: Treibs isolates chlorophyll derivatives from crude oil, explaining the biological origin of
petroleum; 1951: Chargaff's rules are described, highlighting the role of heterocyclic compounds (purines and
pyrimidines) in the genetic code. Heterocycles form by far the largest of the classical divisions of organic chemistry
and are of immense importance biologically, industrially, and indeed to the functioning of any developed human
society. For more than a century, heterocycles have constituted one of the largest area of research in organic
chemistry. Among the approximately 20 million chemical compounds identified by the end of the second
millennium, more than two-thirds are fully or partially aromatic, and approximately half are heterocyclic. The
presence of heterocycles in all kinds of organic compounds of interest in biology, pharmacology, optics, electronics,
material sciences, and so on is very well known. The majority of pharmaceuticals and biologically active
agrochemicals are heterocyclic. There are countless heterocyclic additives and modifiers used in industries as varied
as cosmetics, information storage, and plastics. Heterocycles play an important role in biochemical processes
because the side groups of the most typical and essential constituents of living cells, DNA and RNA, are based on
aromatic heterocycles Balaban, et al.,(2004)3.

Heterocyclic systems occur in a wide variety of natural and synthetic compounds and are essential to life in various
ways. Certain derivatives are produced in nature by various animals and plants. Frequently, the naturally occurring
heterocycles are structurally complex. Most of the sugars and their derivatives including vitamin-C exist largely in
the form of five membered (furan) or six membered (pyran) rings containing one oxygen atom. Cinchona bark has
been used for several hundred years as treatment for malaria. The active constituent is quinine. Many quinolines
were synthesized in the hope of finding a better antimalarial than quinine e.g. Plasmoquine, Pentaquine and
Chloroquine. Caffeine (1,3,7-trimethylxanthine) is the major stimulant in tea and coffee. The most of the alkaloids
which are nitrogenous bases occurring in plants contains heterocyclic ring system. Camphothecin (an alkaloid) has
attracted much interest as an anticancer agent. The powerful antibiotics penicillins and cephalosporins contain a
lactam unit. Heterocycles are of great importance in the metabolic activities. Among these few compounds are
thiamin, riboflavin, nicotinic acid, pyridoxine folic acid, biotin, vitamin E, chlorophyll, haemoglobin, adenine,
purine, pyrimidine, hormones etc. Many natural drugs such as quinine, papaverine, emetine, theophylline, atropine,
procaine, codeine, morphine and reserpine are heterocycles.

The synthetic heterocyclic drugs are still more numerous and include most of the hypnotics, anticonvulsants,
analeptics, antihistaminics, antithyroid drugs, also many antiseptics, fungicides, vasopressor modifiers. Most of the
compounds we know as synthetic drugs such as diazepam, chlorpromazine, isoniazid, metronidazole,
azidothymidine, barbiturates, antipyrine, captopril and methotrexate are heterocycles. Many pesticides are
heterocyclic e.g. the weed-killers paraquat, diquat and simazine, and the insecticides such as rotenome, diazinon and
minazon. Heterocyclic rings constitute a large number of synthetic dyes e.g. mauveine. Many commercially
available dyestuffs are compounds with quinoline ring. Some of the cyanine dyes are of immense importance in
photography. Heterocycles also act as important constituent in plastic and resins such as melanin and cumarone are
polymerized to yield useful plastics and resins. Antioxidant piperidine is used in rubber industry. Heterocycles are
also used as important analytical reagents. These include o-phenanthroline, dipyridyl oxine and nitrone. The ready
availability of furfural from agricultural wastes has resulted in its becoming one of the most valuable industrial
sources of many aliphatic compounds which can be formed from it by simple chemical processes.

506
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
1.2 Azoles
Five membered heterocyclic compounds containing one or more heteroatoms, at least one of which must be nitrogen
are termed as azoles. The simplest azole, pyrrole (1) contains one nitrogen atom. The ring containing two nitrogen
atoms; one oxygen and one nitrogen atom; one sulphur and one nitrogen atom in 1, 2-position are designated as
pyrazole (2), isoxazole (3) and isothiazole (4) respectively. When both the heteroatoms are represent in a 1,3-
relationship then they are referred as imidazole (5), oxazole (6) and thiazole (7) respectively. A five membered ring
containing three nitrogen atoms is known as triazole such as 1, 2,3-triazole (8) and 1,2,4-triazole (9). While a five
membered ring containing four nitrogen atoms is known as tetrazole (10). Azoles are found widely in natural
sources and there are several drugs available which contain azole ring in their molecular framework.

Heterocyclic compounds are a very wide and an expanding area of chemistry as well as pharmacology. Aromatics
and heteroaromatic thiocyanato compounds are useful intermediates in the synthesis of heterocycles such as
imidazole, benzimidazole, benzoxazole, benzothiazoles, thiazines etc. Thiocyanation of aromatics and hetero
aromatics is an important carbon-hetero atom bond formation in organic synthesis Roberto et al., (2000)4.
Thiocyanation approach is the most beneficial process for direct induction of sulphur atom into the organic
molecules Kelly et al., (1993)5. In addition, the thiocyanate group shows a significant functionality in several
anticancer agents Rajendra et al., (1995)6.

Synthesis of various substituted imidazole ,benzimidazole, benzoxazole, tetrazole and quinazolinones from aryl
thiocyanates have received considerable attention during the last two decades as they are endowed with a variety of
biological activities and have a wide range of therapeutic properties.

1.3 Thiocyanate
The thiocyanate radical has a close similarity in its chemical property to halogens, which may be named "pseudo
halogen". Thiocyanate shares its negative charge approximately equally between sulfur and nitrogen. As a
consequence, thiocyanate can act as a nucleophile at either sulfur or nitrogen as it is an ambidentate ligand.

507
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
Thiocyanate is the anion [SCN] . It is the conjugate base of thiocyanic acid. Common derivatives include the
colourless salts potassium thiocyanate and sodium thiocyanate. Organic compounds containing the functional group
SCN are also called thiocyanates. Mercury(II) thiocyanate was formerly used in pyrotechnics Conner et al., (2006)7.

1.4 Imidazole
Imidazole is a planar five-membered heterocyclic ring system with three carbon and two nitrogen atoms at the 1st
and 3rd positions. Imidazole represents an important class of compound being the main component of many naturally
occurring products, as well as synthetic derivatives. Imidazole ring has been of great interest for organic chemist due
to their useful biological and pharmacological aspects. Imidazole derivatives have occupied a unique place in the
field of medicinal chemistry. It is the constituent of several natural compounds like histamine, histamine, biotin,
alkaloids and nucleic acid and a very important class among the medicinal compounds. Large number of imidazole
derivatives have been are being developed for different therapeutic actions, Imidazole is an entity which is being
synthesized in many of its derivative form from past few years; the entity is major source of interest for many of
medicinal chemist to explore its various pharmacological potentials Satyanarayana et al., (2010)8.

1.5 Benzimidazole
Benzimidazole is an important pharmacophore and a privileged structure in medicinal chemistry. This compound is
bicyclic in nature which consists of the fusion of benzene and imidazole. The most prominent benzimidazole
compounds in nature is N-ribosyl-dimethylbenzimidazole, which serves as an axial ligand for cobalt in vitamin B12
Benzimidazole is a heterocyclic aromatic organic compound Shalini et al., (2010)9. This bicyclic compound consists
of the fusion of benzene and imidazole. Heterocyclic compounds are occupied prominent place among various class
of aromatic organic compounds. Benzimidazole are having a variety of therapeutic uses including antitumor,
antifungal, antiparasitic, analgesics, antiviral, antihistamine, as well as use in cardiovascular disease, neurology,
endocrinology, and ophthalmology Day A R et al., (1950)10.

1.6 Benzoxazole
Benzoxazole is an aromatic organic compound with a benzene fused oxazole ring structure. Substituted benzoxazole
derivatives and their analogues such as benzimidazoles and benzothiazoles have been the aim of many researchers
for many years, because they constitute an important class of heterocyclic compounds. The structural variations of
these compounds are that different substituents can be incorporated on the benzene ring and diverse heterocycles
and other active groups can be introduced at the 2-position in order to create good biological activity. The
substitution at second position in benzoxazole skeleton is influential for the biological activity of the molecule
Jauhari et al., (2008)11. Benzoxazole derivatives are biologically significant compounds and known to exhibit
various biological activities such as anticancer, antimicrobial, anti HIV and dopamine D4 agonists Kumar et al.,
(2002)12. Benzoxazoles are also interesting fluorescent probes which show high Stokes shift and present thermal and
photophysical stability due to an excited state intramolecular proton transfer mechanism Holler et al., (2002)13.
Since they interfere with biosynthesis of coloured carotenoids by inhibiting the enzyme phytoene desaturase, they
are studied as potential bleaching herbicides Laber et al., (1999)14. Benzoxazoles can be considered as structural
bioisosteres of naturally occurring nucleotides such as adenine and guanine, which allow them to interact easily with
the biopolymers of a living system. They have shown low toxicity in warm-blooded animals Dunwell et al.,
(1977)15. Benzoxazoles have a number of optical applications such as photoluminescents Claussen, et al., (1981)16,
whitening agents and dye laser Reser, et al., (1972)17. Benzoxazoles have found applications as intermediates for
organic synthesis Fery-Forgues et al., (1993)18.

1.7 Tetrazole
Tetrazole is a 5-membered ring containing 4 nitrogens and 1 carbon. Due to its energetic potential and structural
similarity to carboxylic acids, this ring system has a wide number of applications. Tetrazoles are used in the
pharmaceutical industry in modern anti-hypertensive medications. While this field is fairly developed, the energetic
applications for tetrazoles are fairly unexplored. Throughout this thesis, tetrazole derivatives were synthesized and
investigated as potential energetic materials or components of energetic materials. In most cases, these compounds
were an acceptable substitute for the problematic azido derivatives common in many energetic compounds Mohite
P.B. et al., (2011)19.

Specifically, azido groups are unstable because they react with a variety of compounds. In energetic binders, they
react with the cure catalysts and introduce charges along the polymer chains. The synthesis of tetrazoles is
inherently dangerous because of the explosive and toxic nature of sodium azide. One of the initial goals of this
research was to design a safe and efficient synthesis of tetrazoles.

508
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
1.8 Quinazolinone
Quinazoline are classes of fused heterocycles that are of considerable interest because of the diverse range of their
biological properties, for example, anticancer, diuretic, anti-inflammatory, anticonvulsant and antihypertensive
activities. Quinazolinone will be classified into the following five categories, based on the substitution patterns of
the ring system. Out of the three quinazolinone structures, 4(3H)-quinazolinones are most prevalent, either as
intermediates or as natural products in many proposed biosynthetic pathways. This is partly due to the structure
being derived from the anthranilates (anthranilic acid or various esters, isatoicanhydride, anthranilamide and
anthranilonitrile) while the 2(1H)-quinazolinone is predominantly a product of anthranilonitrile or benzamides with
nitriles. Quinazolinone moiety is a building block for approximately 150 naturally occurring alkaloids. Luotonin A,
Bouchardatine1, and Febrifugine as naturally occurring alkaloids have quinazolinone skeleton. Methaqualone, the
most well-known synthetic quinazolinone drug synthesized for the first time in 1951, has sedativehypnotic effects
Rakhi Rajput et al., (2012)20.

In the most common approach for the synthesis of quinazolinone compounds, 2-aminobenzoic acid or its
derivatives, 2-aminobenzamide, 2-aminobenzonitrile, isatoic anhydride, 2-carbomethoxyphenylisocyanate, N-
arylnitrilium salts, and 4H-3,1-benzoxazinones as appropriate precursors were used. Other methods involve the
reaction of anthranilic acid and the appropriately substituted imidate in a facile one-pot procedure, cycloaddition of
anthranilic acid iminoketene to methylbutyrolactam (via sulfonamide anhydride), reactions of anthranilic acid
derivatives with a wide range of substrates including imidates and imino halides, and microwave-promoted reaction
of anthranilic acid with amines and formic acid (or its ortho ester) and isatoic anhydride.

2. BIOLOGICAL ACTIVITIES
2.1 Medicinal Chemistry
During the pre-scientific period, natural products were used for medicinal purposes, including arrow poisons and
cosmetics. Some notable examples are opium, belladonna, cinchona bark and squill. The science of medicinal
chemistry did not develop until anatomy and physiology reach the status of science.

Now-a-days, the research findings in various science fields, including molecular biology, pharmacology and
enzymology, are applied to the field of medicinal chemistry. Wolff and Coadjutors have pointed out that the present
situation would definitely continue for some more time, before physical measurements and mathematical
calculations would convert medicinal chemistry into an exact science.

2.2 Pharmacotherapeutics
The development of modern pharmacology as a science is fairly recent and this science took shape only after the
invention of screening procedures. Till that period, the treatment was only empirical and experience alone played a
dominant role. A good knowledge of the mode of action of the drug is necessary for the rational treatment of
diseases. Pharmacology, being considered a branch of biology, provides the required scientific data in both animals
and humans. The science of pharmacology includes some allied fields too, such as pharmacognosy, pharmacy,
pharmacodynamics, pharmacokinetics, therapeutics, toxicology and chemotherapy. Pharmacognosy is a science of
identification of drugs, whereas pharmacy is considered as a science of identification, selection, preservation,
compounding and dispensing of drugs. The quantitative biological and therapeutic effects of drugs, and drug action-
chemical structure relation are studied in pharmacodynamics. However, pharmacokinetics describes the absorption,
distribution, metabolism and excretion of drugs. The wordTherapeutics refers to To nurse and this branch of
medicine deals with the cure of diseases. The science of toxicology deals with the detection and measurement of
poisons. Hemotherapy is a science, concerned with the effect of drug on microorganisms and parasites
Helen.P.Kavitha et al., (2000)21.

2.3 Drug Administration

A drug may be applied locally or it may be administered either orally or by injection. The term local application
refers to the application of a material, such as a dusting powder, paste, ointment, lotion or plaster on the surface of
the body. Oral or eternal route is normally the most commonly followed route for drug administration, because it is
safe, convenient and economical. However, this method is not suitable for administering irritant and unpalatable
drugs.

2.4 Toxicity Studies in Animals

Toxicity studies are normally conducted in animals, including mice, rat, guinea pigs, dogs and monkeys with a view
to assess the safety of a drug. The tests, normally carried out, are classified into three types, viz., acute toxicity tests,
chronic toxicity tests and special tests for teratogenecity, mutagenecity and carcinogenecity.

509
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
2.5 Acute Toxicity Tests
The purpose of acute toxicity tests is the same, regardless of the chosen route of exposure. That is, they are
undertaken to investigate the potential adverse effects arising from exposure to a given chemical over a short period
of time. There are many different types of acute effects that could be studied, but the one acute effect, or end-point,
which all chemicals will demonstrate is lethality and it is this which is therefore used as the end-point in this type of
study. The results from acute toxicity tests are graphically represented as a dose-response curve which is often
converted to a straight line plot as it makes the data easier to handle and interpret Laura Robinson et al., (2005)22.

2.6 Lethal Dose, LD50

The term LD50 refers to a dose which is effective in producing a certain expected response in 50% of the animal
group. There is another term, known as, ED50 which is useful in understanding the potency of the drug with respect
to a reference standard. The value of ED50 can be calculated by determining the graded response shown by the drug.
However, when the response is quantal or all-or-none, ED50 is considered to be equal to LD50.

The safety of a drug can be understood based only on the values of both LD50 and ED50. The term therapeutic index
refers to the ratio of LD50 to ED50. The greater the therapeutic index, the safer is the drug. It has been suggested
Kulkarni et al., (1993)23 that the therapeutic index of a drug, having a low margin of safety, has been found to be
close to unity. It is of interest to determine a dose that is effective in most of the animals, namely, ED50 and least
toxic to most of the animals of a group, viz., LD50. The graphical method is normally employed to calculate these
values.

Several methods are available to calculate the LD50 value. One among them is acute toxic class method which
follows the OECD 423 guidelines. It is a stepwise procedure with the use of 3 animals of a single sex per step.
Depending on the mortality and/or the moribund status of the animals, on an average 2-4 steps may be necessary to
allow judgment on the acute toxicity of the test substance. This procedure is reproducible and uses very few animals.
The method as adopted in 1996 was extensively validated in vivo against LD 50 data obtained from the literature,
both nationally and internationally Christina Ruby Stella.P et al., (2013)24.

3. Medicinal Chemistry of Imidazole

Medicinal chemistry is the discipline concerned with determing the influence of chemical structure on biological
activity and in the practice of medicinal chemistry developed from an empirical one involving organic synthesis of
new compound based largely on the modification of structure and then identifies their biological activity
Williams.D.A. et al., (2002)25. Medicinal chemistry concerns with the discovery, development, interpretation and
the identification of mechanism of action of biologically active compounds at the molecular level. Various
biologically active synthetic compounds have five-membered nitrogen-containing heterocyclic ring in their
structures Lednicer D et al., (1997)26.

3.1 Antifungal and anti-bacterial activity

Deepika Sharma et al., (2009)27 (1) have synthesized 2-(substituted phenyl)-1H-imidazole and (substituted phenyl)-
[2-(substituted phenyl)-imidazol-1-yl]-menthanone analogues and screened for antimicrobial activity against gram
positive, gram negative, and fungal species. Norfloxacin used as standard and following compound is the most
potent.

Daniele Zampieri et al., (2007)28 (2) synthesized bis-imidazole derivatives and screened for antifungal and anti-
mycobacterial activity. All compounds showed moderate to good activity against Candida albicans and Candida
glabrata. Miconazole was used as reference drug.

510
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

Shreenivas.M.T et al., (2011)29 (3) Compounds were screened for their in-vitro antibacterial activity against S.
aureus and B. Subtilis employing cup-plate method at the concentration of 100g/ml in nutrient agar media and also
for in-vitro antifungal activity against C. albicans and A. Niger by cup plate method at 100g/ml. concentration
using sabouraud-dextrose agar. DMSO was used as solvent control for antimicrobial activity. Streptomycin was
used as standard for antimicrobial activity. The area of inhibition of zone was measured in cm.

3.2 Anti -inflammatory and analgesic activity

Puratchikody.A et al., (2007)30 studied on (4) 2-substituted-4, 5-diphenyl-1H-imidazoles and checked the anti-
inflammatory activity based on Carrageenan-induced paw edema method. This compound shows maximum activity
and indomethacin was used as reference drug.

3.3 Anticancer activity

Yusuf Ozkay et al., (2010)31 synthesized many novel (5) imidazole-(Benz) azole and imidazole epiperazine
derivatives in order to investigate the anticancer activity. Anticancer activity screening results revealed that these
were the most active compounds in the series. Cisplatin was used as reference drug.

511
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

Cenzo congiu et al., (2008)32 synthesized a series of (6) 1, 4-diarylimidazole-2(3H)-one derivatives and their 2-
thione analogues and evaluated antitumor activity. This Compound showed potent antitumor activity.

Preeti Gupta et al., (2004)33 described anti-mycobacterium tuberculosis activities of ring substituted (7) 1H
imidazole-4-carboxylic acid derivatives and 3-(2-alkyl-1H-imidazole-4-yl)-propionic acid derivatives against durg-
sensitive and durg- resistent M. tuberculosis strains. 2f and 2h compounds were the most potent compounds.

Jyoti Pandey et al., (2009)34 synthesized a series of (8) imidazole derivatives and compounds were screened against
tuberculosis where this compound showed good antitubercular activity.

512
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
3.4 Antidepressant activity
Farzin Hadizadeh et al., (2008)35 synthesized (9) moclobemide analogues by replacing moclobemide phenyl ring
with substituted imidazole and studied for the antidepressant activity using forced swimming test. Analogues 7a-c
was found to be more potent than moclobemide.

3.5 Antiviral activity

Sharma.D et al., (2009)36 synthesized imidazole derivatives and the antiviral screening of (10) (substituted phenyl) -
[2-(substituted phenyl)-imidazol-1-yl]-methanones against viral strains indicated that compounds A selected as the
most potent antiviral agents. Ribavirin was used as standard drug.

3.6 Antilishmanial activity

Kalpana bhandari et al., (2010)37 synthesized a series of (11) substituted aryloxy alkyl and aryloxy aryl alkyl
imidazole and evaluated in vitro as antileishmanial against Leshmania donovani. Among all compounds exhibited
94100% inhibition.

3.7 Anticonvulsant Activity

Bhragual et al., (2010)38 evaluated the anticonvulsant activity by Maximal Electroshock Method (MES).
Substitution of chloro and nitro group at 2nd position in the substituted ring (12) showed significant anticonvulsant
activity without neurotoxicity while hydrogen and 4-nitro substitution did not show the anticonvulsant activity.

513
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

4. Medicinal Chemistry of Benzimidazole

Benzimidazoles are regarded as a promising class of bioactive heterocyclic compounds that exhibit a range of
biological activities. Specifically, this nucleus is a constituent of vitamin-B12. Several benzimidazoles are
commercially available as pharmaceuticals. Benzimidazoles are the most widely studied drugs as anthelmintic.
Recent studies have established that benzimidazole carbamates such as Albendazole (1), mebendazole (2),
flubendazole (3), and fenbendazole (4) inhibit the in vitro growth of Trichomonas vaginalis and G. lamblia. Clinical
reports have shown that albendazole is as effective as metronidazole, the choice drug for the treatment of giardiasis.
Benzimidazole carbomates, well known therapeutic agents used mainly as anthelmintics, have a broad antiparasitic
spectrum of activity, low toxicity and have been used successfully to treat gastrointestinal helminthic infections
Sivakumar.R et al., (2011)39.

4.1 Antibacterial activity

Ramya.V et al., (2009)40 (13) synthesized a series of novel 5-(nitro/bromo)-styryl-2-benzimidazole derivatives
and tested for the antibacterial activity against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis,
and Klebsiella pneumoniae and anti-fungal activity against Candida albicans and Aspergillus fumigates. This was
comparable with ciprofloxacin.

4.2 Analgesic and anti-inflammatory activities

Achar.K.C.S et al., (2010)41 have synthesized a series of (14) 2-methylaminibenzimidazole derivatives and newly
synthesized compounds were screened for analgesic and anti-inflammatory activities. This compound showed
analgesic activity and compared with standard nimesulide drug.

4.3 Antitubercular activity

Shingalapur.R.V et al., (2009)42 synthesized series of novel (15) 5-(nitro/bromo)-styryl-2-benzimidazoles (112)
derivatives and screened for in vitro anti-tubercular activity against Mycobacterium tuberculosis, and these
compounds showed good antitubercular activities. Streptomycin was used as reference drug.

514
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
4.4 Anti-viral activity
Michele Tonelli et al., (2010)43 synthesized seventy six 2-phenylbenzimidazole derivatives and evaluated for
cytotoxicity and anti-viral activity against a panel of RNA and DNA viruses. (16) Compound ([5,6-dichloro-2-(4-
nitrophenyl) benzimidazole]) exhibited a high activity Resulting more potent than reference drugs mycophenolic
acid and 6-azauridine.

4.5 Antiulcer activity

Brumagniez et al., (1990)44 (17) reported the synthesis of 2-(thiopropyne)-5-(imidazol-1-yl) benzimidazole which
exhibited moderate antiulcer activity against ulcer induced by anti-inflammatory agents in rats orally.

Braendstroem et al., (1991)45 (18) reported the synthesis of 2-[(3,4 dimethoxy, 2-pyridyl) methyl, sulfinyl]5-acetyl,
6-methyl benzimidazole which inhibited gastric acid secretion in dogs.

Kohli.P et al., (2007)46 (19) reported the synthesis of 2-[3-methyl, 4(N-methyl-1, 2, 4 triazol-3-yl)1,3-
dithiane]methyl thio benzimidazole which showed high activity against Helicobacter Pylori.

4.6 Antiviral activity

Laila et al., (2008)47 (20) have reported the synthesis of 4-amino-6-(2-methyl-iH-benzimidazol-5-ylamino)-
[1,3,5]triazine-2-carboxylic acid hydrazide which showed the antiviral activity.

4.7 Antitumor activity

Balram Soni1 et al., (2012)48 synthesised and invitro antitumor activity of benzimidazole derivatives (21).

515
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

5. Medicinal Chemistry of Benzoxazole

The majority of pharmaceuticals and biologically active agrochemicals are heterocyclic, while countless additives
and modifiers used in industrial application ranging for cosmetics, reprography, information storage and plastics are
heterocyclic in nature. The heterocyclic ring comprises of very core of the active moiety or the pharmacophore.
Several Benz-fused hetero, bicyclic ring systems as indole, benzothiazole, benzimidazole, benzoxazole, have been
studied and found to be possessing interesting pharmacological activities. Biologically active benzoxazole
derivatives have been known for long time, since they are the isosters of naturally occuring cyclic nucleotides and
they may easily interact with the biopolymers of the organisms Manish Kumar Gautam et al., (2012)49.

5.1 Anti-inflammatory activity

VidyaSagar.J et al., (2010)50 have synthesized methyl-2-(arylideneamino) benoxazole-5-carboxylate derivatives (22)
by reaction of methyl-2-aminobenzoxazole-5-carboxylate and appropriate aromatic aldehydes with absolute alcohol.
Synthesized compounds were screened for their anti-inflammatory activity using carrageenan induced paw oedema
method. The synthesized derivatives showed moderate to potent anti-inflammatory activity when compared to
standard drug Diclofenac sodium.

Reena et al., (2010)51 (23) showed the anti-inflammatory activity of 2-substituted-[(N, N-disubstituted)-1,3-
benzoxazole]-5-carboxamide (49).

Srinivas.A et al., (2010)52 (24) reported the increased anti-inflammatory activity of the compound that is attributed to
the presence of pharmacologically active thiazole ring on the benzoxazole moiety at position-2.

5.2 Anti-microbial activity

Zafer Asim et al., (2004)53 (25) proved the significant antimicrobial activity of benzoxazole.

516
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

Dayakar Gadhe et al., (2010)54 synthesized methyl-2- [2-(arylideneamino) oxazol-4-ylamino] benzoxazole-5-

carboxylate derivatives (26) by the reaction of Methyl-2-(2-aminoxazol-4-ylamino) benzoxazole-5-carboxylate and
appropriate aromatic aldehydes by dissolving in alcohol and finally washed with 1% sodium bicarbonate solution.
The synthesized benzoxazole-5-carboxylate derivatives showed excellent antibacterial activity against Bacillus
subtilis, E.coli etc.

5.3 Cyclooxygenase-2 inhibiting activity

Garrepalli et al., (2011)55 (27) proved that 2-amino-N-(substituted arylidene) benzoxazole-5-carbohydrazide serve as
an excellent candidate for selective COX-2 inhibition.

Srinivas A et al., (2010)56 have synthesized methyl-2- [2-(disubstituted amino) acetamido] benzoxazole-5-
carboxylates (28) by the reaction of a solution of Methyl 2-(2 chloroacetamido) benzoxazole-5-carboxylate in dry
acetone and N, N-dialkylamine. All the synthesized benzoxazole derivatives were shown good to moderate activity.
Some compounds shown the IC50 values of 12.69, 20.13, 23.85 and 21.09 respectively.

5.4 DNA Topoisomerase inhibiting activity

Akbay Aysogul et al., (2003)57 (29) have synthesized 5-phenylacetamidosubstituted-2-phenylbenzoxazole which
inhibits reverse transcriptase activity.

Emine Oksuzoglu et al., (2008)58 (30) and team members investigated the DNA Topoisimerase II inhibitory effects
of 5-methyl-2-substituted benzoxazole.

517
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

Since DNA Topoisomerases are considered as important targets for cancer chemotherapy, the present findings may
provide future opportunities to design and develop new chemotherapeutic agents.

6. Medicinal Chemistry of Tetrazole

Tetrazole and its derivatives have attracted much attention because of their unique structure and applications as
antihypertensive, antiallergic, antibiotic and anticonvulsant agents. Synthesis of tetrazole derivatives is obviously an
important task in modern medicinal chemistry. Although a number of synthetic methods are available, there still
exists a demand for improved protocol which allows an effective transformation in the presence of a wide range of
functional groups. The development of tetrazole chemistry has been largely associated with wide scale of
applications of these classes of compounds in medicine, biochemistry, agriculture and also a large number of
medicinally important tetrazole heterocyclic incorporated drugs approved by the FDA. The tetrazole functionality
plays an important role in medicinal chemistry, primarily due to its ability to serve as bioequivalent (bioisosteres) of
the carboxylic acid group. Heterocyclic derivative is the first approved treatment for the partial agonist of dopamine
D2 receptors; and also heterocyclic derivatives are widely used as antibacterial agents in human and veterinary
medicines. Some of tetrazole containing compounds have been used both as anticancer and antimicrobial agents.

1-Substituted tetrazole derivatives are used as antibiotics and optically active tetrazole containing antifungal
preparations of azole type. There is always a need for new and effective antifungal and antibacterial agents with
broad spectrum antibacterial and antifungal activities. It was decided to exploit this interest by ascertaining the
molecules features essential for activity and utilizing them to develop a new class of drugs. Prompted by the various
biological activities of tetrazole and its substituted derivatives, we envisioned our approach towards the synthesis of
a novel series of 1- substituted tetrazole derivatives and study their biological activities. The objective of the present
study was to synthesize new substituted tetrazole derivatives and to evaluate their antibacterial and antifungal
properties Dhayanithi Varadaraji et al., (2010)59.

6.1 Antibacterial activity

Adnan. A et al., (2011)60 (31 and 32) reported tetrazolo [1,5a] quinoline as a potential promising new scaffold for
the synthesis of novel anti-inflammatory and antibacterial agents. The four compounds were proved to be active
anti-inflammatory agents against indomethacin.

Umarani Natrajan et al., (2010)61 (33) reported a facile design and efficient synthesis of Schiffs bases of tetrazolo
[1,5-a] quinoxalines as potential anti-inflammatory and anti-microbial agents and few of them exhibited promising
activity.

518
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

Md Salahuddin et al., (2009)62 (34) reported the synthesis of some novel Benzo Thieno [2, 3-d] pyrimidines and
synthesized compounds are active against the bacteria like Bacillus subtilis, Bacillus pumilis, Escherichia coli and
Staphylococcus aureus but the Thieno [2, 3-d] pyrimidine derivative containing tetrazole ring shows moderate
antibacterial activity.

Mosaad Sayed Mohamed et al., (2009)63 (35) reported the synthesis of N-(3-cyano-1-(3-methylphenyl)-4,5-
diphenyl-1H-pyrrol-2-yl)-acetamides (5c), 2-amino-1-(4-methoxyphenyl)-4,5-diphenyl-3-tetrazolo-1Hpyrroles(5d)
and found to possess potent antimicrobial activity.

Hari N. Patil et al., (2010)64 (36, 37 and 38) have reported synthesis and evaluation of a series of 1-substituted
tetrazole derivatives as antimicrobial agents a series of novel 1-substituted tetrazole derivatives were synthesized
and evaluated for their antibacterial and antifungal activity. All the derivatives were efficiently synthesized by four
steps process. In this study, thiazole attached tetrazole derivatives were most active than the piperazine attached
tetrazole derivatives.

519
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

Adnan A Bekhit et al., (2004)65 (39) have synthesised three series of tetrazolo [1,5-a]quinoline derivatives. The
newly synthesized compounds were evaluated for their anti-inflammatory and antimicrobial activities. Four
compounds were proved to be as active as indomethacin in animal models of inflammation.

6.2 Antifungal activity

Ram Shankar Upadhayaya et al., (2004)66 (40) reported synthesis of novel substituted tetrazoles having antifungal
activity. The derivatives containing piperidine are found to be highly active.

Movie Popat. B et al., (2010)67 (41) have reported synthesis and antifungal activity of 3-aryl 1-(5-phenyl-1H-
tetrazol-1-yl)prop-2-en-1-one and evaluated for antifungal activity using cup and plate method in which compounds
containing chloro group are highly active.

520
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________

6.3 Analgesic activity

Rajasekaran A et al., (2004)68 (42) have reported on synthesis and analgesic evaluation of some 5-[b-(10-
phenothiazinyl) ethyl]-1-(acyl)-1, 2, 3, 4-tetrazoles.

6.4 Anti-inflammatory activity

Ilango Kaliappan et al., (2010)69 (43) reported, a novel synthetic methodology of Schiffs bases incorporating
tetrazolo quinoxalines .All the newly synthesized heterocycles have been screened for their in vitro antimicrobial
and anti-inflammatory activities. Few of them exhibited promising activity. The ambient conditions, excellent
product yields and easy work up procedures make this synthetic strategy a better protocol for the synthesis of newer
Schiffs derivatives.

7. Medicinal Chemistry of Quinazolinone

The quinazolinone skeleton is a frequently encountered heterocycles in medicinal chemistry literature with
applications including antibacterial, analgesic, anti-inflammatory, antifungal, antimalarial, CNS depressant,
anticonvulsant, anticoccidial, anti-parkinsonism, and cancer activities. Little number of quinazolinones was reported
as potent chemotherapeutic agents in the treatment of tuberculosis. For example 3-aryl-6, 8-dichloro-2H-1, 3-
benzoxazine-2, 4(3H) - diones and 3-arylquinazoline-2, 4(1H, 3H)-diones as anti-mycobacterial agents,
quinazolinone derivatives as antitubercular agents.

Compounds of both synthetic and natural origin comprising a diverse group of chemical structure have been
reported as antileishmial agents. These include mostly nitrogen heterocyclic such as quinolines, purine, pyrimidine,
acidine, phenothiazines, bisbenzamides, pyrazolol, pyridine, benzothiazole and imidazolines Rakhi Rajput et al.,
(2012)70.

7.1 Antileukemic activity

Raffa et al., (2004)71 synthesized 3-(3-Methylisoxazol-5-yl) and 3-(pyrimidin-2-yl)-2 styrylquinazolin-4(3H)-ones
(44 and 45) by refluxing in acetic acid the corresponding 2-methylquinazolinones with the benzoic aldehyde for 12

521
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
h and tested for their in vitro antileukemic activity against L-1210 (murine leukemia), K-562 (human chronic
myelogenous leukemia) and HL-60 (human leukemia) cell lines showing in some cases good activity.

7.2 Antimalarial activity

Werbel et al., (1987)72 synthesized a variety of analogues of 2, 4-diamino-6-[(aryl) thio] quinazolines with known
antimalarial properties wherein the 4-amino group was replaced by hydrazine and hydroxyamino moieties and they
found that such changes reduce markedly the antimalarial properties of this series. The compound (46) was tested
against a normal drug-sensitive strain of Plasmodium berghei in mice by the parenteral route.

7.3 Antioxidant activity

Selvam et al., (2010)73 synthesized a series of novel thiazole quinazoline derivatives by condensation of different
aromatic aldehydes with 4-nitro aniline and chemical structures of the synthesized compounds were confirmed by
means of IR, 1H-NMR, mass spectroscopy and elemental analyses and screened for antioxidant activity by DPPH
radical assay, nitric oxide scavenging activity and hydrogen peroxide scavenging activity and reported that
synthesized compounds (47, 48 and 49) were found to have the most potent anti-oxidant activity.

7.4 Antileishmanial activity

Agarwal KC et al., (2009)74 synthesized 4-(Substituted-benzylidine)-2-substituted-5, 6 dihydrobenzo[h]quinazoline
and 4-(substitutedbenzylidine) - 2-substituted-3, 4, 5, 6 tetrahydrobenzo[h]quinazoline from 2-(substituted-

522
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
benzylidine)tetralone-1 and several substituted guanidine sulfates and evaluated for their in vitro antileishmanial
activity and they reported that compounds (50,51 and 52) show promising antileishmanial activity against
Leishmania donovani.

7.5 Analgesic activity

Hemlatha et al., (2011)75 synthesized a series of some novel 2, 3-disubstituted quinazolinone derivatives by
condensing 2-methyl/2-phenyl/6-bromo-2-methyl/6-bromo-2-phenyl/6, 8-dibromo-2-methyl/ 6, 8-dibromo-2-phenyl
benzoxazines with compounds containing amino group were confirmed by IR, 1H-NMR, 13C-NMR and Mass
spectral data and evaluated for their analgesic activity and they reported that compound (53) show promising
analgesic activity compared to standard drug Diclofenac sodium.

CONCLUSION

The above mentions clearly shown that the structurally simple imidazole, benzimidazole, benzoxazole, tetrazole and
quinazolinone ring plays an important role in medicinal chemistry and the related research has been being unusually
active subjects. A large amount of work has been made toward imidazole, benzimidazole, benzoxazole, tetrazole and
quinazolinone medicinal chemistry. Numerous outstanding achievements revealed that imidazole, benzimidazole,
benzoxazole, tetrazole and quinazolinone compounds possess extensively potential application as medicinal drugs,
diagnostic agents, and pathologic probes. In particular, a large number of imidazole, benzimidazole, benzoxazole,
tetrazole and quinazolinone compounds as clinical anticancer, antibacterial, antifungal, antineuropathic,
antihypertensive, antihistaminic, antiparasitic agents, and so on have been successfully developed, marketed, and
extensively used in the clinic in preventing and treating various types of diseases with low toxicity, high
bioavailability, and good biocompatibility and curative effects. An expanding effort from all over the world has been

523
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
directly focusing on imidazole, benzimidazole, benzoxazole, tetrazole and quinazolinone compounds for possible
clinical application in the diagnosis and treatment of various types of diseases. Excitingly, an increasing number of
imidazole, benzimidazole, benzoxazole, tetrazole and quinazolinone derivatives have been becoming clinical drug
candidates in actively ongoing research and developments. All these have strongly suggested the infinite potentiality
of imidazole, benzimidazole, benzoxazole, tetrazole and quinazolinone derivatives in medicinal field.

Convincingly, with the continuous efforts directly toward imidazole, benzimidazole, benzoxazole, benzothiazole,
tetrazole and quinazolinone medicinal chemistry and the progress in other disciplines such as cell biology, molecular
biology, pharmacology, and materials science. A growing number of imidazole, benzimidazole, benzoxazole,
tetrazole and quinazolinone drugs with better efficacy, lower toxic and superior pharmacokinetic characteristics, and
effective diagnostic agents and pathologic probes will be used in the clinic and make remarkable contributions for
the protection of human health.

Acknowledgement
The authors thank the Principal, Management and PG & Research Department of Chemistry, of Bishop Heber
College, for the facilities provided to carry out this work.

REFERENCES

[1] Eicher. T, Hauptmann S. The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications.
2nd ed. Wiley-VCH, 2003.
[2] Campaigne, E. Journal Chemical Education 1986, 6, 860.
[3] Balaban, A. T, Oniciu, D. C, Katritzky, A. R. Chem. Rev. 2004, 104, 2777.
[4] Roberto Margarita, Chiara Mercanti, Luca Parlanti, Giovanni Piancatelli, European Journal of Organic
Chemistry, 2000, 10, 1865-1870.
[5] Kelly T R, Kim M H, Certis A D M, Journal Organic Chemistry, 1993, 58, 5855-5861.
[6] Rajendra G M, Jinfang L, Andreas C, Cathy F T, Michael H, Min Y, Clarissa G, John M P,Richard C M, Robert
M M, Carcinogenesis, 1995, 16, 399.
[7] Conner G E, Wijkstrom-Frei C, Randell S H,Fernandez V E, FEBS Letters, 2006, 581, 2, 271-278.
[8] Satyanarayana V S, Sivakumar A, Ghosh A R, Journal of Pharmacy Research, 2010, 3, 2327-2331.
[9] Shalini K, Sharma P K, Kumar N, Der Pharmacia Sinica, 2010, 1, 36-47.
[10] Day A R, Electronic Mechanisms of Organic Reactions, American Book Company, New York, 1st edition,
1950.
[11] auhari, P. K.; Bhavani, A.; Varalwar, S.; Singhal, K.; Raj, P. Medicinal Chemistry Research 2008, 17, 412.
[12] Kumar, D.; Jacob, M. R.; Reynoldsa, M. B.; Kerwin, S. M. Bioorganic & Medicinal Chemistry Letters, 2002,
10, 3997.
[13] Holler, M. G.; Campo, L. F.; Brandelli, A.; Stefani, V. J. Photochem Photobiology A: Chemistry 2002, 149,
217.
[14] Laber, B.; Usunow, G.; Wiecko, E.; Franke, W.; Franke, H.; Kohn, A. Pesticide Biochem Physiology, 1999, 63,
173.
[15] Dunwell, D. W.; Evans, D. Journal of Medicinal Chemistry, 1977, 20, 797.
[16] Claussen, U.; Harnisch, H. European Patent Applications, 1981, 25, 136.
[17] Reser, A.; Leyshon, L. J.; Saunders, D.; Mijovic, M. V.; Bright, A.; Bogie, J. Journal American. Chemical
Society. 1972, 94, 2414.
[8] Fery-Forgues, S.; Paillous, N. Journal Organic Chemistry. 1993, 58, 3176.
[19] Mohite P.B., Pandhare R.B. and Khanage S.G. Analele Universitii din Bucureti Chimie (serie nou),
2011, 20, 2, 107 113.
[20] Rakhi Rajput, Abhinav Prasoon Mishra, Academic Sciences, International Journal of Pharmacy and
Pharmaceutical Sciences, 2012, 4, 2.
[21] Helen P Kavitha, Ph.D. Thesis, Syntheses and study of Biological Activities of some Organic Compounds,
Bharathidasan University, 2000.
[22] Laura Robinson, Ian Thorn, Toxicology and Ecotoxicology in Chemical Safety Assessment, 2005, Blackwell
Publishing Ltd. ISBN: 978-1-405-11559-9.
[23] Kulkarni S K, Handbook of Experimental Pharmacology, 2nd edition, Vallabh Prakashan, New Delhi, 1993, 78.
[24] Christina Ruby Stella.P Ph.D. Thesis synthesis characterization and biological activities of some novel
Organic compounds Bharathidasan University, 2013.
[25] Williams.D.A and T. L. Lemke; Foyes Principles of medicinal chemistry, Williams and Wilkins, Lippincott,
2002, 5, 36.
[26] Lednicer D, Mitscher L.A, Inorganic Chemistry of Drug Synthesis, Wiley Interscience NewYork, 1997, 1, 226.

524
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
[27] Deepika Sharma, B. Narasimhan, P. Kumar, V. Judge, R. Narang, E. De Clercq, J. Balzarini, European
Journal of Medicinal Chemistry, 2009, 44, 23472353.
[28] Daniele Zampieri, M. G. Mamolo, L. Vio, E. Banfi, G. Scialino, M. Fermeglia, M. Ferrone Bioorganic &
Medicinal Chemistry, 2007, 15, 74447458.
[29] Shreenivas.M.T, B.E. Kumara Swamy, G.R. Srinivasa, B.S. Sherigara, Der Pharma Chemica, 2011, 3, 2, 156-
161.
[30] Puratchikodya.A and M. Doble, Bioorganic & Medicinal Chemistry, 2007, 15, 10831090.
[31] Yusuf Ozkay, I. Iskar, Z. Incesu, G. e. Akalin, European Journal of Medicinal Chemistry, 2010, 3, 1-9.
[32] Cenzo Congiu., M. T. Cocco and V. Onnis, Bioorganic & Medicinal Chemistry Letters, 2008, 18, 989993.
[33] Preeti Gupta, S. Hameed, R. Jain, European Journal of Medicinal Chemistry, 2004, 39,805814.
[34] Jyoti Pandey, T. K. Vinod, V.S.Shyam, C.Vinita, S. Bhatnagar , S Sinha ,A.N. Gaikwad, R. P. Tripathi,
European Journal of Medicinal Chemistry, 2009, 44, 3350-3355.
[35] Farzin Hadizadeh, H. Hosseinzadeh, Vahideh-Sadat Motamed-Shariaty M. Seifib, S. Kazemi, Iranian Journal
of Pharmaceutics Research, 2008, 7, 1, 29-33.
[36] Sharma.D, B. Narasimhan, P. Kumar, V. Judge, R. Narang, E. De Clercq, J. Balzarini, European Journal of
Medicinal Chemistry, 2009, 44, 23472353.
[37] Kalpana bhandari, N. Srinivas, V. K. Marrapu, A. Verma, S. Srivastava, S. Gupta, Bioorganic & Medicinal
Chemistry Letters, 2010, 20, 291293.
[38] Bhragual D D, Kumar N, Drabu S, Journal of Chemical and Pharmaceutical Research, 2010, 2, 2, 345-349.
[39] Sivakumar.R, R. Pradeepchandran, K. N. Jayaveera, P. Kumarnallasivan, P.R.Vijaianand, R. International
Journal of Pharmaceutical Research, 2011, 3, 3. 19-31.
[40] Ramya.V, R. V. Shingalapur, K. M. Hosamani, R.S. Keri, European Journal of Medicinal Chemistry, 2009,
44, 42444248.
[41] Achar. K. C.S, K.M.Hosamani, H.R.Seetharamareddy, European Journal of Medicinal Chemistry, 2010, 45,
20482054.
[42] Shingalapur.R.V, K. M. Hosamani, R.S. Keri, European Journal of Medicinal Chemistry, 2009, 44, 4244
4248.
[43] Michele Tonelli, M. Simone, B. Tasso, F. Novelli, V. Boido, Bioorganic & Medicinal Chemistry, 2010, 18,
29372953.
[44] Brumagniez Nicole, Timur G, Jean L., Michele L., European Patent No. 385850, 1990.
[45] Braendstroem A, Lindberg E, Lennart P, Sunden G, World Patent No. 9119712, 1991.
[46] Kohli P, Srivastava S D, Srivastava S K, Journal of the Chinese Chemical Society, 2007, 54, 1003-1010.
[47] Laila A, Abou-zeid, Saudi pharmaceutical journal, 2008, 16, 2,321-325.
[48] Balram Soni, Mahendra Singh Ranawat, Anil Bhandari and Rambabu Sharma, International Journal of Drug
Research and Technology, 2012, 2, 7, 479-485.
[49] Manish Kumar Gautam, Sonal, Neeraj Kant Sharma, Priyanka, Keshari Kishore Jha, International Journal of
ChemTech Research, 2012, 4, 2, 640-650.
[50] VidyaSagar. J, Srinivas A., Swathi K., Sarangapani M., Journal of Chemical Pharmaceutical Research, 2010,
2, 2, 213-219.
[51] Reena M, Kiran G, Rajyalakshmi G, Venkateshwar J, Sarangapani M, Acta Pharmaceutica Sinica, 2010, 45,
6,730-734.
[52] Srinivas Ampati, Vidyasagar J, Swathi K, Sarangapani M, Journal of Chemical Pharmaceutical Research,
2010, 2, 2, 213-219
[53] Zafer Asim Kaplancikli, Gulhan Turan-Zitouni, Gilbert Revial, Kiymet Guven, Archives of Pharmacal
Research, 2004, 27, 11, 1081-1085.
[54] Dayakar Gadhe, Chilumula N.R., Gudipati R., Srinivas A., Manda S., International Journal of Chemistry
Research, 2010, 1, 2, 1-6.
[55] Garepalli S, Sarangapani M, Chilukala S, Der Pharmacia Lettre, 2011, 3, 2, 427-432.
[56] Srinivas Ampati, Vidyasagar J, Swathi K, Sarangapani M, Journal of Chemical Pharmaceutical Research,
2010, 2, 2, 213-219
[57] Akbay A, Oren I, Arpaci O T, Sener E A, Yalcin I, Arzneim Forsch Drug Research, 2003, 53, 4, 266-271.
[58] Emine Oksuzoglu , Gulbas B T, Alper S, Arpaci O T, Ertan T, Yildiz I, Diril N Aki E S, Yalcin I, J. Journal of
Enzyme Inhibition and Medicinal Chemistry, 2008, 23, 1, 37-42.
[59] Dhayanithi Varadaraji, Syed S. Suban, Venkat R. Ramasamy, Kumaran Kubendiran, Jai Sankar K. G.
Raguraman, Suchetha K. Organic Communications 3:3, 2010, 45-56.
[60] Adnan A. Kadi, Journal of Saudi Chemical Society, 2011, 15, 95100.
[61] Umarani Natrajan, Der Pharma Chemica, 2010, 2, 1, 159-167.
[62] Md Salahuddin, Sanjay Singh and S.M.Shantakumar, Journal of chemistry, 2009, 2, 1,167-173.
[63] Mosaad Sayed Mohamed, Ramdan Ahmed ELDomany, Rania Helmy ABD EL-Hameed, Acta Pharm. 2009,
59,145158.

525
Maruthamuthu et al J. Chem. Pharm. Res., 2016, 8(5):505-526
______________________________________________________________________________
[64] Hari N. Patil, Dhayanithi Varadaraji, Syed S.Suban, Venkat R. Ramasamy, Kumaran Kubendiran, Jai Sankar,
Organic Communications, 2010, 3.3, 45-56.
[65] Adnan A. Bekhit a, Ola A. El-Sayed, Elsayed Aboulmagd, JiYoung Park, European Journal of Medicinal
Chemistry, 2004, 39, 249255.
[66] Ram Shankar Upadhayaya, Sanjay Jain, Neelima Sinha, Nawal Kishore, Ramesh Chandra Sudershan K. Arora,
European Journal of Medicinal Chemistry, 2004, 39, 579592.
[67] Movie Popat B. Mohite, Vaidhun H. Bhaskar, Orbital-The electronic journal of chemistry, 2010, 2, 3, 311-315.
[68] Rajasekaran. A, P.P. Thampi, European Journal of Medicinal Chemistry, 2004, 39, 273279.
[69] Ilango Kaliappan, Umarani Natarajan, Narendra Kumar Singh, Der Pharma Chemica, 2010, 2, 1, 159-167.
[70] Rakhi Rajput, Abhinav Prasoon Mishra, Academic Sciences, International Journal of Pharmacy and
Pharmaceutical Sciences, 2012, 4, 2.
[71] Raffa D, Daidone G, Maggio B, Cascioferro S, Plescia F, Schillaci.D. IL Farmaco, 2004, 59, 451455.
[72] Werbel LM, Degnan M.J. Journal of Medicinal Chemistry, 1987, 30, 2151-2154.
[73] Selvam T P, Kumar PV, Kumar AS. Research in Biotechnology, 2010, 1, 38-48.
[74] Agarwal KC, Sharma V, Shakya N, Gupta S, Bioorganic and Medicinal Chemistry Letters, 2009, 19, 5474
5477.
[75] Hemalatha K, Girija K. International Journal of Pharmacy and Pharmaceutical Sciences. 2011, 3, 2, 103-106.

526